AIM
UTHR icon

Ada Investment Management’s United Therapeutics UTHR Stock Holding History

Ada Investment Management’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-3,606
Closed -$489K – 536
2015
Q3 		$489K Buy
+3,606
New +$578K 0.25% 116

Other funds holding UTHR

ACM
Americafirst Capital Management Roseville, California $74M AUM 13.49% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Ada Investment Management's UTHR Position: Q4 2015 in Review

Ada Investment Management sold out of United Therapeutics (UTHR) in Q4 2015, closing a stake of 3,606 shares — an estimated $489K sold.

Ada Investment Management first reported a position in UTHR in Q3 2015 and held it in 1 quarter. The position peaked at $489K in Q3 2015. 386 funds tracked by Wall St. Rank hold UTHR as of Q4 2015.

  • Ada Investment Management reported no remaining United Therapeutics position as of Q4 2015 after selling out during the quarter.
  • Ada Investment Management sold 3,606 United Therapeutics shares in Q4 2015, an estimated $489K.
  • Ada Investment Management first reported a position in United Therapeutics in Q3 2015 and held it in 1 quarter.
  • Ada Investment Management's United Therapeutics position peaked at $489K in Q3 2015.
  • 386 funds tracked by Wall St. Rank held United Therapeutics as of Q4 2015.

Based on Ada Investment Management's 13F filing for Q4 2015, filed 19 Feb 2016.